The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Prospects for Vaccine Prevention of Meningococcal Infection
Open accessAbstract
SUMMARY: Neisseria meningitidis is the leading cause of bacterial meningitis in the United States and worldwide. A serogroup A/C/W-135/Y polysaccharide meningococcal vaccine has been licensed in the United States since 1981 but has not been used universally outside of the military. On 14 January 2005, a polysaccharide conjugate vaccine that covers meningococcal serogroups A, C, W-135, and Y was licensed in the United States for 11- to 55-year-olds and is now recommended for the routine immunization of adolescents and other high-risk groups. This review covers the changing epidemiology of meningococcal disease in the United States, issues related to vaccine prevention, and recommendations on the use of the new vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308
Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
Adams, W. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020055031 · Cited by 696
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571
Maiden, M. C., & Stuart, J. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08679-8 · Cited by 418 · cited 4×
“In addition, cost-benefit analyses of meningococcal conjugate vaccines have generally failed to take the potential substantial impact of herd immunity into account, a major limitation given the demonstrated impact of conjugate vaccines on the incidence of disease in unimmunized persons (3, 224, 280, 384).”
BackgroundInfluentialRamsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
Chatelet, I. P. D., Traore, Y., Gessner, B. D., Antignac, A., Naccro, B., Njanpop-Lafourcade, B.-M., Ouedraogo, M. S., Tiendrebeogo, S. R., Varon, E., & Taha, M. K. (2005) · Clinical Infectious Diseases · doi:10.1086/426436 · Cited by 158
Risk of Meningococcal Infection in College Students
Harrison, L. H. (1999) · JAMA · doi:10.1001/jama.281.20.1906 · Cited by 154
Self-citation
Cited by
Global epidemiology of meningococcal disease
Harrison, L. H., Trotter, C. L., & Ramsay, M. E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.063 · Cited by 755
Self-citationAhmed, Q. A., Arabi, Y. M., & Memish, Z. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68429-8 · Cited by 411
Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates
Schneider, M. C., Prosser, B. E., Caesar, J. J. E., Kugelberg, E., Li, S., Zhang, Q., Quoraishi, S., Lovett, J. E., Deane, J. E., Sim, R. B., et al. (2009) · Nature · doi:10.1038/nature07769 · Cited by 314
Ceyhan, M., Gürler, N., Ozsurekci, Y., Keser, M., Aycan, A. E., Gurbuz, V., Salman, N., Camcioglu, Y., Dinleyici, E. C., Ozkan, S., et al. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29678 · Cited by 60
“It has been shown that introduction of conjugate vaccines can dramatically reduce meningitis disease incidence, if vaccines are administered to the target population with high vaccine coverage.(1,14,37) Hib and PCV-13 vaccines are already available for infants starting from two months of age in the Turkish NIP and the…”
Background
Metadata
- Authors
- Harrison, L. H.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2006-01
- Volume
- 19
- Issue
- 1
- Pages
- 142-164
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2141226147
- Cited by
- 178
- References
- 7
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospects for Vaccine Prevention of Meningococcal Infection. https://app.cochat.ai/papers/10.1128/cmr.19.1.142-164.2006
- The paper
- Harrison, L. H. (2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.19.1.142-164.2006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.